ReviewRSC advances2019
Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade.
Min Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewRSC advances2019
Min Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.